tiprankstipranks
Trending News
More News >
Bone Therapeutics S.A. (GB:0R55)
LSE:0R55
UK Market

Bone Therapeutics (0R55) Income Statement

Compare
2 Followers

Bone Therapeutics Income Statement

Last quarter (Q4 2024), Bone Therapeutics's total revenue was €0.00, a decrease of -100.00% from the same quarter last year. In Q4, Bone Therapeutics's net income was €-5.26M. See Bone Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 0.00€ 543.00K€ 296.00K€ 312.00K€ 1.00M
Gross Profit
€ -196.00K€ 543.00K€ 296.00K€ 987.00K€ 1.00M
Operating Expenses
€ 8.08M€ 7.38M€ 2.52M€ 1.18M€ 16.02M
Depreciation and Amortization
€ 196.00K€ 234.00K€ 60.00K€ 13.00K€ 173.00K
EBITDA
€ -4.84M€ -6.80M€ -2.26M€ -864.00K€ -14.83M
Operating Income
€ -8.27M€ -7.04M€ -2.32M€ -1.19M€ -15.02M
Other Income/Expenses
€ 1.56M€ -21.99M€ -731.00K€ 205.00K€ -737.00K
Pretax Income
€ -6.71M€ -29.03M€ -3.05M€ -984.00K€ -15.75M
Net Income
€ -4.77M€ -28.78M€ -2.04M€ -984.00K€ -11.94M
Per Share Metrics
Basic EPS
€ -0.02€ -0.21€ -0.02€ -0.05€ -1.02
Diluted EPS
€ -0.02€ -0.21€ -0.02€ -0.05€ -1.02
Weighted Average Shares Outstanding
231.34M 137.04M 120.13M 21.31M 11.72M
Weighted Average Shares Outstanding (Diluted)
231.34M 137.04M 120.13M 21.31M 11.72M
Currency in EUR

Bone Therapeutics Earnings and Revenue History